Patents by Inventor JANSSEN BIOTECH, INC.

JANSSEN BIOTECH, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Differentiation of Human Embryonic Stem Cells into Pancreatic Endoderm
    Publication number: 20140162359
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides methods to produce a population of pancreatic endoderm cells, wherein the initial seeding density of undifferentiated epluripotent cells is defined.
    Type: Application
    Filed: May 7, 2013
    Publication date: June 12, 2014
    Applicant: Janssen Biotech, Inc.
    Inventor: Janssen Biotech, Inc.
  • METHODS FOR PREDICTING ANTI-INTEGRIN ANTIBODY RESPONSE
    Publication number: 20130316923
    Abstract: The present invention relates to methods and procedures for predicting responsiveness to anti-integrin ?v monoclonal antibody.
    Type: Application
    Filed: March 14, 2013
    Publication date: November 28, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventor: Janssen Biotech, Inc.
  • Non-Natural Consensus Albumin Binding Domains
    Publication number: 20130316952
    Abstract: Non-natural albumin binding domains, polynucleotides encoding thereof and methods of making and using these domains and polynucleotides are useful in controlling the half-life of therapeutic molecules for patients.
    Type: Application
    Filed: May 23, 2013
    Publication date: November 28, 2013
    Applicant: Janssen Biotech, Inc.
    Inventor: Janssen Biotech, Inc.
  • Differentiation of Human Embryonic Stem Cells into Single Hormonal Insulin Positive Cells
    Publication number: 20130189777
    Abstract: The present invention provides methods to promote the differentiation of pluripotent stem cells. In particular, the present invention provides methods to produce a population of cells, wherein greater than 10% of the cells in the population express markers characteristic of single hormonal pancreatic beta cells.
    Type: Application
    Filed: December 7, 2012
    Publication date: July 25, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventor: Janssen Biotech, Inc.
  • Methods of Treating Hepatitis With Anti-TNF alpha Antibodies
    Publication number: 20130183298
    Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-? (TNF?) and are useful in vivo diagnosis and therapy of a number of TNF?-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
    Type: Application
    Filed: March 5, 2013
    Publication date: July 18, 2013
    Applicants: NEW YORK UNIVERSITY, JANSSEN BIOTECH, INC.
    Inventors: Janssen Biotech, Inc., New York University
  • Methods of Treating Giant Cell Arteritis With Anti-TNF Alpha Antibodies
    Publication number: 20130171136
    Abstract: Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-? (TNF?) and are useful in vivo diagnosis and therapy of a number of TNF?-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
    Type: Application
    Filed: March 5, 2013
    Publication date: July 4, 2013
    Applicants: NEW YORK UNIVERSITY, JANSSEN BIOTECH, INC.
    Inventors: Janssen Biotech, Inc., New York University
  • Method for Treating Psoriatic Arthritis By Administering An Anti-IL-12 Antibody
    Publication number: 20130129617
    Abstract: An anti-IL-12 antibody that binds to a portion of the IL-12 protein corresponding to at least one amino acid residue selected from the group consisting of residues 15, 17-21, 23, 40-43, 45-47, 54-56 and 58-62 of the amino acid sequence of the p40 subunit of IL-12, including isolated nucleic acids that encode at least one anti-IL-12 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof have applications in treating IL-12-related disorders, such as psoriatic arthritis.
    Type: Application
    Filed: November 6, 2012
    Publication date: May 23, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventor: Janssen Biotech, Inc.
  • Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody
    Publication number: 20130064760
    Abstract: Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as Crohn's disease.
    Type: Application
    Filed: November 7, 2012
    Publication date: March 14, 2013
    Applicant: JANSSEN BIOTECH, INC.
    Inventor: JANSSEN BIOTECH, INC.